Use of complementary and alternative medicine in patients with gynecologic cancer: A systematic review

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 17, 2015, Pages 7847-7852

  Akpunar, Dercan ^a   Bebis, Hatice ^a   Yavan, Tulay ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Alternative medicine; Complementary medicine; Gynecologic cancer

Indexed keywords

PLANT MEDICINAL PRODUCT; VITAMIN;

ADVERSE EFFECTS; ALTERNATIVE MEDICINE; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMAN; PROCEDURES;

COMPLEMENTARY THERAPIES; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; PLANT PREPARATIONS; VITAMINS;

EID: 84949762581     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.17.7847     Document Type: Article

References (30)

1. Akyuz A, Dede M, Cetinturk A, et al (2007). Self-application of complementary and alternative medicine by patients with gynecologic cancer. Gynecol Obstet Invest, 64, 75-81.
2. Amanak K, Karaoz B, Sevil U (2013). Alternative/Complementary Medicine and Women's Health. TAF Prev Med Bulletin, 12, 441-8.
3. Andersen MR, Sweet ES, Lowe KA, et al (2012). Potentially dangerous complementary and alternative medicine (cam) use by overian cancer patients. J Gynecol Surg, 28, 116-20.
4. Arye-Ben E, Schiff E, Raz OG, et al (2014). Integrating a complementary medicine consultation for women undergoing chemotherapy. Int J Gynaecol Obstet, 124, 51-4.
5. Arye EB, Schiff E, Steiner M, et al (2012). Attitudes of patients with gynecological and breast cancer toward integration of complementary medicine in cancer care. Int J Gynecol Cancer, 22, 146-53.
6. Can G (2013). Complementary approaches in breast cancer: Non-pharmacological approaches. [Meme kanserinde tamamlayici yaklasimlar: Non-farmakolojik Yaklasimlar]. J Be Healthy [Sağlikla Hemşirelik Dergisi (Turkish Article)], 13, 54-5.
7. Fascing PA, Thiel F, Nicolaisen-Murmann K, et al (2007). Association of complementary with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer, 15, 1277-84.
8. Finnane A, Liu Y, Battistutta D, et al (2011). Lymphedema after breast or gynecological cancer: use and effectiveness of mainstream and complementary therapies. J Altern Complement Med, 17, 867-9.
9. Gruenigen VEV, White LJ, Kirven MS, et al (2001). A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients. Int J Gynecol Cancer, 11, 205-9.
10. Gungormus Z, Kiyak E (2012). Evaluation of the knowledge, attitude and behaviors of individuals who suffer from pain towards complementary and alternative medicines. Agri, 24, 123-9.
11. Horneber M, Bueschel G, Dennert G, et al (2012). How many cancer patients use complementary and alternative medicine: a systematic review and meta analysis. Integr Cancer Ther, 11, 187-03.
12. International Childhood Cancer Day 2015. [Internet, World Health Organization Web Site]. [updated 2015 June 29].
13. Karayagiz-Muslu G, Ozturk C (2008). Complementary and alternative treatments and their practice in children. department of pediatric nursing, ege and dokuz eylul university nursing schools. Izmir, Turkey. Turk J Pediatr, 51, 62-7.
14. Kav S, Hanoglu Z, Algier L (2008). Use of complementary and alternative medicine by cancer patients in turkey: a literature review. Int J Hematol Oncol, 18, 32-8.
15. Lee MM, Lin SS, Wrensch MR, et al (2000). Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst, 92, 42-7.
16. Manheimer E, Berman B (2003). NCCAM support for the Cochrane Collaboration CAM Field. Complementary Therapies in Med, 11, 268-271.
17. Mao JJ, Palmer CS, Healy KE, et al (2011). Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surviv, 5, 8-17.
18. Molassiotis AM, Milovics L, Pantelis V, et al (2006). Complementary and alternative medicine use in patients with gynecological cancers in Europe. Int J Gynecol Cancer, 16, 219-24.
19. Navo MA, Phan J, Vaughan C, et al (2004). Assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol, 22, 671-7.
20. Powell CB, Dibble SL, Dallera JE, et al (2002). Use of herbs in women diagnosed with overian cancer. Int J Gynecol Cancer, 12, 214-7.
21. Pud D, Kaner E, Morag A, et al (2005). Use of complementary and alternative medicine among cancer patients in Israel. Eur J Oncol Nurs, 9, 124-30.
22. Richirdson ME, Masse LC, Nanny K, et al (2004). Discrepant views of oncologists and cancer patients on complementary/alternative medicine. Support Care Cancer, 12, 797-804.
23. Scott JA, Kearney N, Hummerston S, et al (2005). Use of complementary and alternative medicine in patients with cancer: A UK survey. Eur J Oncol Nurs, 9, 131-7.
24. Swisher E, Cohn D, Goff BA, et al (2002). Use of complementary and alternative medicine among women with gynecologic cancers. Gynecol Oncol, 84, 363-7.
25. Tam KF, Cheng KL, Ng TY, et al (2005). The behaviors of seeking a second opinion from other health-care professionals and the utilization of complementary and alternative medicine in gynecologic cancer patients. Support Care Cancer, 13, 679-84.
26. Tokem Y (2006). The use of complementary and alternative treatment in patients with asthma. Tuberk Toraks [Turkish Article], 54, 189-96.
27. Turan N, Ozturk A, Kaya N (2010). A new responsibility in nursing: complementary therapy. J Maltepe University Nursing Sci Art [serial online], 2, 103-8.
28. Upchurch DM, Chyu L (2005). Use of complementary and alternative medicine among American women. Womens Health Issues, 15, 5-13.
29. Verhoef MJ, Balneaves LG, Boon HS, et al (2005). Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther, 4, 274-86.
30. Wieland LS, Manheimer E, Berman BM (2011). Development and classification of an operational definition of complementary and alternative medicine for the cochrane collaboration. Altern Ther Health Med, 17, 50-9.